Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling

Cell Reports(2020)10.1016/j.celrep.2020.02.014Source: DataRank Database

Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 42 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access42 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.98)OA: goldTopics (65)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Nisha G. Sosale,Aizhen Xiao,Qing Zhong ORCID,Benjamin Purow ORCID,Matthew J. Lazzara ORCID

Live enrichment

PubMed:32160544 OpenAlex:https://openalex.org/W3012023838

NIH

Grant: 1S10RR025694-01

In Vivo Optical Imaging Scanner for Small Animal Research

UVA Cancer Center National Cancer Institute

Grant: P30-CA044579-23

American Cancer Society Research Scholar

Grant: RSG-15-010-01-CDD

National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems

Grant: 1511853

NSF Graduate Research Fellowship Program

Grant: DGE-1321851

National Cancer Institute

Grant: P30CA044579

FWCI

1.98

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttps://doi.org/10.1016/j.celrep.2020.02.014

publisherhttps://doi.org/10.1016/j.celrep.2020.02.014

publisherhttps://api.elsevier.com/content/article/PII:S2211124720301686?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124720301686?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32160544

Fields of Study

Cancer, Hypoxia, and MetabolismCancer Cells and MetastasisLiver physiology and pathology0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AnimalsCell SurvivalFemaleFibroblast Growth FactorsGlioblastomaHumansLigandsMembrane ProteinsMice, NudeModels, BiologicalPhosphorylationRNA, MessengerSignal TransductionUp-RegulationGene Expression Regulation, NeoplasticProto-Oncogene Proteins c-mycNF-kappa BReceptors, Fibroblast Growth FactorGenes, ReporterDrug Resistance, NeoplasmCell Line, TumorProtein Kinase InhibitorsIntracellular Signaling Peptides and ProteinsExtracellular Signal-Regulated MAP KinasesErbB Receptors

Keywords

Autocrine signallingMAPK/ERK pathwayCancer researchReceptor tyrosine kinaseFibroblast growth factor receptorSignal transductionFibroblast growth factorTyrosine kinaseBiologyCell biologyReceptorBiochemistryQH301-705.5Cell SurvivalMice, NudeLigandsModels, BiologicalGenes, ReporterCell Line, TumorAnimalsHumansBiology (General)PhosphorylationExtracellular Signal-Regulated MAP KinasesProtein Kinase InhibitorsIntracellular Signaling Peptides and ProteinsNF-kappa BMembrane ProteinsErbB ReceptorsFibroblast Growth FactorsGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmFemaleGlioblastoma

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being